Mark Howarth

Professor Mark Howarth is the Sheild Chair of Pharmacology at the University of Cambridge's Department of Pharmacology. His research focuses on innovating protein technologies for therapeutic and vaccine design, with affiliations across the Cambridge Infectious Diseases interdisciplinary center and collaborations spanning North America, Europe, and biotech/pharma industries.

Research Highlights:

• Vaccine development platforms applied to SARS-CoV-2, influenza, malaria, HIV, and veterinary diseases
• Gastrobodies for targeting gastrointestinal infections through acid-resistant antibody mimetics
• Protein superglues (SpyTag/SpyCatcher) enabling synthetic biology and antibody team engineering
• NeissLock technology for covalent protein targeting in cancer immunotherapy

Scientific Achievements:

• Royal Society of Chemistry Norman Heatley Prize
• Founder of SpyBiotech (now in clinical trials)
• Technologies adopted by over 1000 academic groups and biotech companies

Lab Members: Gabrielle Admans, Claudia Driscoll, Rory Hills, Anthony Keeble, Lasya Vankayala, Deepak Chand, Yujia Cui, Emily Nassen, Dawid Maciorowski, Ana Rossi